Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Burchett

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomesRussell B Van Dyke, Kunjal Patel, George K Siberry, et al.
HIV Medicine|November 20, 2014
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokineticsF T Aweeka, C Hu, L Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without InfectionGeorge K Siberry, Kunjal Patel, William J Bellini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Atazanavir pharmacokinetics with and without tenofovir during pregnancyMark Mirochnick, Brookie M Best, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruptionGeorge K Siberry, Kunjal Patel, Russell B Van Dyke, et al.
The Journal of Infectious Diseases|September 30, 2000
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected childrenJ C Lindsey, M D Hughes, R E McKinney, et al.
Pediatrics|May 23, 2001
The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected childrenT L Miller, B E Mawn, E J Orav, et al.
The New England Journal of Medicine|August 5, 1999
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study GroupP M Garcia, L A Kalish, J Pitt, et al.
AIDS (London, England)|February 14, 2006
Impact of pregnancy on abacavir pharmacokineticsBrookie M Best, Mark Mirochnick, Edmund V Capparelli, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomesRussell B Van Dyke, Kunjal Patel, George K Siberry, et al.
HIV Medicine|November 20, 2014
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokineticsF T Aweeka, C Hu, L Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without InfectionGeorge K Siberry, Kunjal Patel, William J Bellini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Atazanavir pharmacokinetics with and without tenofovir during pregnancyMark Mirochnick, Brookie M Best, Alice M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruptionGeorge K Siberry, Kunjal Patel, Russell B Van Dyke, et al.
The Journal of Infectious Diseases|September 30, 2000
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected childrenJ C Lindsey, M D Hughes, R E McKinney, et al.
Pediatrics|May 23, 2001
The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected childrenT L Miller, B E Mawn, E J Orav, et al.
The New England Journal of Medicine|August 5, 1999
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study GroupP M Garcia, L A Kalish, J Pitt, et al.
AIDS (London, England)|February 14, 2006
Impact of pregnancy on abacavir pharmacokineticsBrookie M Best, Mark Mirochnick, Edmund V Capparelli, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
Pageof 8